Evidence for association of DNA sequence variants in the phosphatidylinositol-4-phosphate 5-kinase IIα gene (PIP5K2A) with schizophrenia

Molecular Psychiatry

Volumn 11, Issue 9, 2006, Pages 837-846

  Schwab, S G ^a,b,c   Knapp, M ^c   Sklar, P ^d,e   Eckstein, G N ^f   Sewekow, C ^c   Borrmann Hassenbach, M ^g   Albus, M ^g   Becker, T ^c   Hallmayer, J F ^h   Lerer, B ⁱ   Maier, W ^c   Wildenauer, D B ^b,j  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF BONN   (Germany)

^d BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f INSTITUTE OF EPIDEMIOLOGY   (Germany)

^g KLINIKUM MÜNCHEN OST   (Germany)

^h STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^j GRAYLANDS HOSPITAL   (Australia)

more..

Author keywords

Candidate gene; Linkage disequilibrium; Non synonymous amino acid exchange; Phosphoinositide cell signalling; Single nucleotide polymorphism

Indexed keywords

ASPARAGINE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 4 PHOSPHATE 5 KINASE IIALPHA; PHOSPHATIDYLINOSITOL 4 PHOSPHATE KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE; SERINE; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FAMILY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC LINKAGE; HUMAN; HUMAN CELL; INTRON; MAJOR CLINICAL STUDY; PHOSPHOINOSITIDE METABOLISM; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

BASE SEQUENCE; CHROMOSOME MAPPING; DNA; EXONS; FAMILY; GENETIC VARIATION; GENOTYPE; HUMANS; INTRONS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SIBLINGS; VARIATION (GENETICS);

EID: 33748068453     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/sj.mp.4001864     Document Type: Article

References (77)

1. Gottesman I. Schizophrenia Genesis.WH Freeman: New York, 1991.
2. Risch NJ. Searching for genetic determinants in the new millennium. Nature 2000; 405: 847-856.
3. Riley BP, McGuffin P. Linkage and associated studies of schizophrenia. Am J Med Genet 2000; 97: 23-44.
4. Schizophrenia Linkage Collaborative Group for Chromosomes 3a. Additional support for schizophrenia linkage on chromosomes 6 and 8: a multicenter study. Schizophrenia Linkage Collaborative Group for Chromosomes 3, 6 and 8. Am J Med Genet 1996; 67: 580-594.
5. Kendler KS, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F et al. Evidence for a schizophrenia vulnerability locus on chromosome 8p in the Irish Study of High-Density Schizophrenia Families. Am J Psychiat 1996; 153: 1534-1540.
6. Blouin JL, Dombroski BA, Nath SK, Lasseter VK, Wolyniec PS, Nestadt G et al. Schizophrenia susceptibility loci on chromosomes 13q32 and 8p21. Nat Genet 1998; 20: 70-73.
7. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S et al. Neuregulin 1 and susceptibility to schizophrenia. Am J Hum Genet 2002; 71: 877-892.
8. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E et al. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Hum Genet 2003; 72: 83-87.
9. Schwab SG, Albus M, Hallmayer J, Honig S, Borrmann M, Lichtermann D et al. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat Genet 1995; 11: 325-327.
10. Straub RE, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F et al. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: evidence for genetic heterogeneity. Nat Genet 1995; 11: 287-293.
11. Turecki G, Rouleau GA, Joober R, Mari J, Morgan K. Schizophrenia and chromosome 6p. Am J Med Genet 1997; 74: 195-198.
12. Wang S, Sun CE, Walczak CA, Ziegle JS, Kipps BR, Goldin LR et al. Evidence for a susceptibility locus for schizophrenia on chromosome 6pter-p22. Nat Genet 1995; 10: 41-46.
13. Moises HW, Yang L, Kristbjarnarson H, Wiese C, Byerley W, Macciardi F et al. An international two-stage genome-wide search for schizophrenia susceptibility genes. Nat Genet 1995; 11: 321-324.
14. Nurnberger Jr JI, Foroud T. Chromosome 6 workshop report. Am J Med Genet 1999; 88: 233-238.
15. Hwu HG, Lin MW, Lee PC, Lee SF, Ou-Yang WC, Liu CM. Evaluation of linkage of markers on chromosome 6p with schizophrenia in Taiwanese families. Am J Med Genet 2000; 96: 74-78.
16. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV et al. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 2002; 71: 337-348.
17. Van Den Bogaert A, Schumacher J, Schulze TG, Otte AC, Ohlraun S, Kovalenko S et al. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet 2003; 73: 1438-1443.
18. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M et al. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 2003; 72: 185-190.
19. Kirov G, Ivanov D, Williams NM, Preece A, Nikolov I, Milev R et al. Strong evidence for association between the dystrobrevin binding protein 1 gene (DTNBP1) and schizophrenia in 488 parent-offspring trios from Bulgaria. Biol Psychiat 2004; 55: 971-975.
20. Funke B, Finn CT, Plocik AM, Lake S, DeRosse P, Kane JM et al. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am J Hum Genet 2004; 75: 891-898.
21. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci USA 2002; 99: 13675-13680.
22. Chowdari KV, Mirnics K, Semwal P, Wood J, Lawrence E, Bhatia T et al. Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet 2002; 11: 1373-1380.
23. Brzustowicz LM, Simone J, Mohseni P, Hayter JE, Hodgkinson KA, Chow EW et al. Linkage disequilibrium mapping of schizophrenia susceptibility to the CAPON region of chromosome 1q22. Am J Hum Genet 2004; 74: 1057-1063.
24. Millar JK, Wilson-Annan JC, Anderson S, Christie S, Taylor MS, Semple CA et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 2000; 9: 1415-1423.
25. Hennah W, Varilo T, Kestila M, Paunio T, Arajarvi R, Haukka J et al. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sexdependent effects. Hum Mol Genet 2003; 12: 3151-3159.
26. Duan J, Martinez M, Sanders AR, Hou C, Saitou N, Kitano T et al. Polymorphisms in the trace amine receptor 4 (TRAR4) gene on chromosome 6q23.2 are associated with susceptibility to schizophrenia. Am J Hum Genet 2004; 75: 624-638.
27. Pimm J, McQuillin A, Thirumalai S, Lawrence J, Quested D, Bass N et al. The Epsin 4 gene on chromosome 5q, which encodes the clathrin-associated protein enthoprotin, is involved in the genetic susceptibility to schizophrenia. Am J Hum Genet 2005; 76: 902-907.
28. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiat 2005; 10: 804.
29. Faraone SV, Matise T, Svrakic D, Pepple J, Malaspina D, Suarez B et al. Genome scan of European-American schizophrenia pedigrees: results of the NIMH Genetics Initiative and Millennium Consortium. Am J Med Genet 1998; 81: 290-295.
30. Foroud T, Castelluccio PF, Koller DL, Edenberg HJ, Miller M, Bowman E et al. Suggestive evidence of a locus on chromosome 10p using the NIMH genetics initiative bipolar affective disorder pedigrees. Am J Med Genet 2000; 96: 18-23.
31. Levinson DF, Holmans P, Straub RE, Owen MJ, Wildenauer DB, Gejman PV et al. Multicenter linkage study of schizophrenia candidate regions on chromosomes 5q, 6q, 10p, and 13q: schizophrenia linkage collaborative group III. Am J Hum Genet 2000; 67: 652-663.
32. Rice JP, Goate A, Williams JT, Bierut L, Dorr D, Wu W et al. Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 1, 6, 8, 10, and 12. Am J Med Genet 1997; 74: 247-253.
33. Schwab SG, Hallmayer J, Albus M, Lerer B, Hanses C, Kanyas K et al. Further evidence for a susceptibility locus on chromosome 10p14-p11 in 72 families with schizophrenia by nonparametric linkage analysis. Am J Med Genet 1998; 81: 302-307.
34. Straub RE, MacLean CJ, Martin RB, Ma Y, Myakishev MV, Harris-Kerr C et al. A schizophrenia locus may be located in region 10p15-p11. Am J Med Genet 1998; 81: 296-301.
35. DeLisi LE, Shaw SH, Crow TJ, Shields G, Smith AB, Larach VW et al. A genome-wide scan for linkage to chromosomal regions in 382 sibling pairs with schizophrenia or schizoaffective disorder. Am J Psychiat 2002; 159: 803-812.
36. Holliday E, Mowry B, Chant D, Nyholt D. The importance of modelling heterogeneity in complex disease: application to NIMH Schizophrenia Genetics Initiative data. Hum Genet 2005; 117: 160-167.
37. Schwab SG, Hallmayer J, Albus M, Lerer B, Eckstein GN, Borrmann M et al. A genome-wide autosomal screen for schizophrenia susceptibility loci in 71 families with affected siblings: support for loci on chromosome 10p and 6. Mol Psychiat 2000; 5: 638-649.
38. Risch N, Spiker D, Lotspeich L, Nouri N, Hinds D, Hallmayer J et al. A genomic screen of autism: evidence for a multilocus etiology. Am J Hum Genet 1999; 65: 493-507.
39. Doughman RL, Firestone AJ, Anderson RA. Phosphatidylinositol phosphate kinases put PI4,5P(2) in its place. J Membr Biol 2003; 194: 77-89.
40. Anderson RA, Boronenkov IV, Doughman SD, Kunz J, Loijens JC. Phosphatidylinositol phosphate kinases, a multifaceted family of signaling enzymes. J Biol Chem 1999; 274: 9907-9910.
41. Rameh LE, Tolias KF, Duckworth BC, Cantley LC. A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate. Nature 1997; 390: 192-196.
42. Fyer A, Endicott J, Mannuzza S, Klein D. Schedule for Affective Disorders and Schizophrenia-Lifetime Version (SADS-LA). New York State Psychiatric Institute: New York, 1985.
43. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness. Development and reliability of the OPCRIT system. Arch Gen Psychiat 1991; 48: 764-770.
44. Spitzer R, Endicott J, Robins E. Diagnostic Criteria for a Selected Group of Functional Disorders. New York State Psychiatric Institute: New York, 1978.
45. Orita M, Iwahana H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms. Proc Natl Acad Sci USA 1989; 86: 2766-2770.
46. Chen X, Levine L, Kwok PY. Fluorescence polarization in homogeneous nucleic acid analysis. Genome Res 1999; 9: 492-498.
47. Hamilton SP, Slager SL, Helleby L, Heiman GA, Klein DF, Hodge SE et al. No association or linkage between polymorphisms in the genes encoding cholecystokinin and the cholecystokinin B receptor and panic disorder. Mol Psychiat 2001; 6: 59-65.
48. Sklar P, Gabriel SB, McInnis MG, Bennett P, Lim YM, Tsan G et al. Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Brain-derived neutrophic factor. Mol Psychiat 2002; 7: 579-593.
49. Buetow KH, Edmonson M, MacDonald R, Clifford R, Yip P, Kelley J et al. High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proc Natl Acad Sci USA 2001; 98: 581-584.
50. Kokoris M, Dix K, Moynihan K, Mathis J, Erwin B, Grass P et al. High-throughput SNP genotyping with the Masscode system. Mol Diagn 2000; 5: 329-340.
51. Becker T, Knapp M. Maximum-likelihood estimation of haplotype frequencies in nuclear families. Genet Epidemiol 2004; 27: 21-32.
52. Zhao H, Zhang S, Merikangas KR, Trixler M, Wildenauer DB, Sun F et al. Transmission/disequilibrium tests using multiple tightly linked markers. Am J Hum Genet 2000; 67: 936-946.
53. Knapp M, Becker T. Family-based association analysis with tightly linked markers. Hum Hered 2003; 56: 2-9.
54. Becker T, Knapp M. A powerful strategy to account for multiple testing in the context of haplotype analysis. Am J Hum Genet 2004; 75: 561-570.
55. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics 1987; 117: 331-341.
56. Li J, Ji L. Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrix. Heredity 2005; 95: 221-227.
57. Nyholt DR. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765-769.
58. Kim UJ, Birren BW, Slepak T, Mancino V, Boysen C, Kang HL et al. Construction and characterization of a human bacterial artificial chromosome library. Genomics 1996; 34: 213-218.
59. Boronenkov IV, Anderson RA. The sequence of phosphatidylinositol-4- phosphate 5-kinase defines a novel family of lipid kinases. J Biol Chem 1995; 270: 2881-2884.
60. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 76-80.
61. Hinds DA, Stuve LL, Nilsen GB, Halperin E, Eskin E, Ballinger DG et al. Whole-genome patterns of common DNA variation in three human populations. Science 2005; 307: 1072-1079.
62. Harwood AJ. Lithium and bipolar mood disorder: the inositol-depletion hypothesis revisited. Mol Psychiat 2005; 10: 117-126.
63. Sewekow CA, Schwab SG, Knapp M, Hallmayer J, Eckstein GN, Gabel S et al. Association of SNPs with schizophrenia on chromosome 10p, a region with previously detected linkage. Am J Med Genet 2003; 122B: 244.
64. Schwab SG, Sklar P, Hallmayer J, Albus M, Rietschel M, Lerer B et al. Association of SNPs with schizophrenia on chromosome 10p, a region with previously detected linkage. Am J Med Genet 2001; 105: 562.
65. Bakker SC, Hoogendoorn CLC, Hendriks J, Verzijlbergen K, Caron S, Verduijn W et al. The PIP5K2A and RGS4 genes are differentially associated with deficit and non-deficit schizophrenia. Genes Brain Behav, 13 April 2006 [E-pub ahead of print].
66. Castellino AM, Parker GJ, Boronenkov IV, Anderson RA, Chao MV. A novel interaction between the juxtamembrane region of the p55 tumor necrosis factor receptor and phosphatidylinositol-4-phosphate 5-kinase. J Biol Chem 1997; 272: 5861-5870.
67. Schwab SG, Mondabon S, Knapp M, Albus M, Hallmayer J, Borrmann-Hassenbach M et al. Association of tumor necrosis factor alpha gene -G308A polymorphism with schizophrenia. Schizophr Res 2003; 65: 19-25.
68. Boin F, Zanardini R, Pioli R, Altamura CA, Maes M, Gennarelli M. Association between -G308A tumor necrosis factor alpha gene polymorphism and schizophrenia. Mol Psychiat 2001; 6: 79-82.
69. York JD, Odom AR, Murphy R, Ives EB, Wente SR. A phospholipase C-dependent inositol polyphosphate kinase pathway required for efficient messenger RNA export. Science 1999; 285: 96-100.
70. Boronenkov IV, Loijens JC, Umeda M, Anderson RA. Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors. Mol Biol Cell 1998; 9: 3547-3560.
71. Carricaburu V, Lamia KA, Lo E, Favereaux L, Payrastre B, Cantley LC et al. The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation. Proc Natl Acad Sci USA 2003; 100: 9867-9872.
72. Emamian ES, Hall D, Birnbaum MJ, Karayiorgou M, Gogos JA. Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia. Nat Genet 2004; 36: 131-137.
73. Schwab SG, Hoefgen B, Hanses C, Hassenbach MB, Albus M, Lerer B et al. Further evidence for association of variants in the AKT1 gene with schizophrenia in a sample of European sib-pair families. Biol Psychiat 2005; 58: 446-450.
74. Rao VD, Misra S, Boronenkov IV, Anderson RA, Hurley JH. Structure of type IIbeta phosphatidylinositol phosphate kinase: a protein kinase fold flattened for interfacial phosphorylation. Cell 1998; 94: 829-839.
75. Cargill M, Daley GQ. Mining for SNPs: putting the common variants - common disease hypothesis to the test. Pharmacogenomics 2000; 1: 27-37.
76. Lander ES. The new genomics: global views of biology. Science 1996; 274: 536-539.
77. Stopkova P, Saito T, Fann CS, Papolos DF, Vevera J, Paclt I et al. Polymorphism screening of PIP5K2A: a candidate gene for chromosome 10p-linked psychiatric disorders. Am J Med Genet B Neuropsychiatr Genet 2003; 123: 50-58.